Correlation Between Summit Therapeutics and Codexis

Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and Codexis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and Codexis into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Summit Therapeutics PLC and Codexis, you can compare the effects of market volatilities on Summit Therapeutics and Codexis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of Codexis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and Codexis.

Diversification Opportunities for Summit Therapeutics and Codexis

-0.37

Correlation Coefficient

Summit Therapeutics  Codexis

Very good diversification

The 3 months correlation between Summit and Codexis is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and Codexis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Codexis and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with Codexis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Codexis has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and Codexis go up and down completely randomly.

Pair Corralation between Summit Therapeutics and Codexis

Given the investment horizon of 90 days Summit Therapeutics PLC is expected to generate 1.31 times more return on investment than Codexis. However, Summit Therapeutics is 1.31 times more volatile than Codexis. It trades about 0.22 of its potential returns per unit of risk. Codexis is currently generating about 0.01 per unit of risk. If you would invest  1,928  in Summit Therapeutics PLC on October 27, 2024 and sell it today you would earn a total of  448.00  from holding Summit Therapeutics PLC or generate 23.24% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Summit Therapeutics PLC  vs.  Codexis

Summit Therapeutics PLC

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Summit Therapeutics PLC are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak primary indicators, Summit Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Codexis

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Codexis are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Codexis unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Summit Therapeutics and Codexis

The main advantage of trading using opposite Summit Therapeutics and Codexis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, Codexis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Codexis will offset losses from the drop in Codexis' long position.

The idea behind Summit Therapeutics PLC and Codexis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.